Literature DB >> 22426596

Primary central nervous system anaplastic large-cell lymphoma mimicking lymphomatosis cerebri.

Toshiya Sugino1, Takeshi Mikami, Yukinori Akiyama, Masahiko Wanibuchi, Tadashi Hasegawa, Nobuhiro Mikuni.   

Abstract

Primary central nervous system lymphoma (PCNSL) is usually diffuse large B-cell lymphoma. Anaplastic large-cell lymphoma (ALCL) rarely occurs in the central nervous system. PCNSL always presents as single or multiple nodular contrast-enhancing mass lesions within T2-hyperintense areas on magnetic resonance imaging (MRI). Infrequently, diffuse infiltrating change with little contrast enhancement called lymphomatosis cerebri can be seen in PCNSL. In this report, we describe a 75-year-old immunocompetent man who had progressive dementia. On MRI, diffuse white matter lesions with little contrast enhancement were observed to gradually progress, which was clinically consistent with his worsening condition. A biopsy specimen revealed non-destructive, diffusely infiltrating, anaplastic large CD30-positive lymphoma, indicating a diagnosis of ALCL. After the biopsy, he was treated by whole brain irradiation (total 46 Gy) and focal boost irradiation (total 14 Gy). However, his performance status worsened and there was no symptom improvement. The patient died 8 months after symptom onset. The clinical course, diagnostic workup, pathologic correlates, and treatment outcomes are described herein.

Entities:  

Mesh:

Year:  2012        PMID: 22426596     DOI: 10.1007/s10014-012-0094-0

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  8 in total

1.  Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis.

Authors:  Madhu P Menon; Alina Nicolae; Hillary Meeker; Mark Raffeld; Liqiang Xi; Armin G Jegalian; Douglas C Miller; Stefania Pittaluga; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

2.  Neurocognitive features distinguishing primary central nervous system lymphoma from other possible causes of rapidly progressive dementia.

Authors:  Mariel B Deutsch; Mario F Mendez
Journal:  Cogn Behav Neurol       Date:  2015-03       Impact factor: 1.600

3.  Primary anaplastic large cell lymphoma in the dura of the brain: case report and prediction of a favorable prognosis.

Authors:  Min-Kyung Kim; Chang-Ho Cho; Woo-Jung Sung; Hun-Mo Ryoo; Ho-Jun Lee; Sung-Won Youn; Kwan-Kyu Park
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

Review 4.  Lymphomatosis cerebri: a rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literature.

Authors:  Cristina Izquierdo; Roser Velasco; Noemí Vidal; Juan José Sánchez; Andreas A Argyriou; Sarah Besora; Francesc Graus; Jordi Bruna
Journal:  Neuro Oncol       Date:  2015-09-27       Impact factor: 12.300

5.  Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement.

Authors:  Shino Magaki; Radha Satyadev; Zesheng Chen; Kathryn S Yung; Harry V Vinters; Marsha C Kinney; Jonathan W Said
Journal:  Brain Tumor Pathol       Date:  2021-11-18       Impact factor: 3.298

6.  Clinical presentation of anaplastic large-cell lymphoma in the central nervous system.

Authors:  Masashi Nomura; Yoshitaka Narita; Yasuji Miyakita; Makoto Ohno; Shintaro Fukushima; Takashi Maruyama; Yoshihiro Muragaki; Soichiro Shibui
Journal:  Mol Clin Oncol       Date:  2013-04-30

7.  Neuroradiological features of lymphomatosis cerebri: A systematic review of the English literature with a new case report.

Authors:  Long Li; Jia-Hui Rong; Jie Feng
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

8.  Lymphomatosis cerebri: a rare variant of primary central nervous system lymphoma and MR imaging features.

Authors:  Hui Yu; Bo Gao; Jing Liu; Yong-Cheng Yu; Mark S Shiroishi; Ming-Ming Huang; Wen-Xiu Yang; Zhi-Zhong Guan
Journal:  Cancer Imaging       Date:  2017-10-05       Impact factor: 5.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.